Exact Sciences Buys Genomic Health for $2.8 Billion.
Cancer diagnostic test manufacturer Exact Sciences bought Genomic Health in a $2.8 billion deal. The sale is not likely to affect the companies' current products-Cologuard and Oncotype DX assays-but may promote development of new tests to detect other cancers.